Medigene AG
XETRA:MDG1
Medigene AG
XETRA:MDG1
Price:
1.235 EUR
-3.14%
Updated:
May 23, 2024
Medigene AG
Cash from Operating Activities
|
Medigene AG
Cash from Operating Activities Peer Comparison
Comparables:
BNTX
MOR
CVAC
IMTX
BIO
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Medigene AG
XETRA:MDG1
|
Cash from Operating Activities
-€15.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Operating Activities
€5.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Operating Activities
-€298.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Cash from Operating Activities
-€267.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Cash from Operating Activities
€18.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Cash from Operating Activities
-€2.7m
|
CAGR 3-Years
50%
|
CAGR 5-Years
36%
|
CAGR 10-Years
-8%
|
See Also
What is Medigene AG's Cash from Operating Activities?
Cash from Operating Activities
-15.1m
EUR
-15.1m
EUR
Based on the financial report for Dec 31, 2023, Medigene AG's Cash from Operating Activities amounts to -15.1m EUR.
What is Medigene AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-8%
-8%
The average annual Cash from Operating Activities growth rates for Medigene AG have been 15% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
